FDA inspection
Novartis Pharmaceutical Comp.: FDA inspection ending Oct 2, 2002
FDA inspection 239549 · No Action Indicated (NAI) · Summit, NJ
Key facts
| Inspection ID | 239549 |
|---|---|
| Firm | Novartis Pharmaceutical Comp. |
| FEI number | 2210776 |
| Address | 556 Morris Ave |
| City | Summit |
| State | NJ |
| ZIP | 07901-1330 |
| Fiscal year | 2003 |
| Inspection end date | Oct 2, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data